Glennon RA, Dukat M, Grella B, Hong S, Costantino L, Teitler M, et al. (August 2000). "Binding of beta-carbolines and related agents at serotonin (5-HT(2) and 5-HT(1A)), dopamine (D(2)) and benzodiazepine receptors". Drug and Alcohol Dependence. 60 (2): 121–132. doi:10.1016/s0376-8716(99)00148-9. PMID10940539.
Fortunato JJ, Réus GZ, Kirsch TR, Stringari RB, Fries GR, Kapczinski F, et al. (October 2010). "Chronic administration of harmine elicits antidepressant-like effects and increases BDNF levels in rat hippocampus". Journal of Neural Transmission. 117 (10): 1131–1137. doi:10.1007/s00702-010-0451-2. PMID20686906. S2CID21595062.
López-Muñoz F, Alamo C (2009-05-01). "Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today". Current Pharmaceutical Design. 15 (14): 1563–1586. doi:10.2174/138161209788168001. PMID19442174.
Wernicke C, Hellmann J, Zieba B, Kuter K, Ossowska K, Frenzel M, et al. (January 2010). "9-Methyl-beta-carboline has restorative effects in an animal model of Parkinson's disease". Pharmacological Reports. 62 (1): 35–53. doi:10.1016/s1734-1140(10)70241-3. PMID20360614. S2CID16729205.
Hamann J, Wernicke C, Lehmann J, Reichmann H, Rommelspacher H, Gille G (March 2008). "9-Methyl-beta-carboline up-regulates the appearance of differentiated dopaminergic neurones in primary mesencephalic culture". Neurochemistry International. 52 (4–5): 688–700. doi:10.1016/j.neuint.2007.08.018. PMID17913302. S2CID24226033.
Polanski W, Reichmann H, Gille G (June 2011). "Stimulation, protection and regeneration of dopaminergic neurons by 9-methyl-β-carboline: a new anti-Parkinson drug?". Expert Review of Neurotherapeutics. 11 (6): 845–860. doi:10.1586/ern.11.1. PMID21651332. S2CID24899640.
Schwarz MJ, Houghton PJ, Rose S, Jenner P, Lees AD (June 2003). "Activities of extract and constituents of Banisteriopsis caapi relevant to parkinsonism". Pharmacology, Biochemistry, and Behavior. 75 (3): 627–633. doi:10.1016/s0091-3057(03)00129-1. PMID12895680. S2CID28243440.
Brierley DI, Davidson C (January 2013). "Harmine augments electrically evoked dopamine efflux in the nucleus accumbens shell". Journal of Psychopharmacology. 27 (1): 98–108. doi:10.1177/0269881112463125. PMID23076833. S2CID40115950.
Hemmateenejad B, Abbaspour A, Maghami H, Miri R, Panjehshahin MR (August 2006). "Partial least squares-based multivariate spectral calibration method for simultaneous determination of beta-carboline derivatives in Peganum harmala seed extracts". Analytica Chimica Acta. 575 (2): 290–299. Bibcode:2006AcAC..575..290H. doi:10.1016/j.aca.2006.05.093. PMID17723604.
Herraiz T, González D, Ancín-Azpilicueta C, Arán VJ, Guillén H (March 2010). "beta-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO)". Food and Chemical Toxicology. 48 (3): 839–845. doi:10.1016/j.fct.2009.12.019. hdl:10261/77694. PMID20036304.
Lake RJ, Blunt JW, Munro MH (1989). "Eudistomins from the New Zealand ascidian Ritterella sigillinoides". Aust. J. Chem. 42 (7): 1201–1206. doi:10.1071/CH9891201.
Badre A, Boulanger A, Abou-Mansour E, Banaigs B, Combaut G, Francisco C (April 1994). "Eudistomin U and isoeudistomin U, new alkaloids from the Caribbean ascidian Lissoclinum fragile". Journal of Natural Products. 57 (4): 528–533. doi:10.1021/np50106a016. PMID8021654.
Davis RA, Carroll AR, Quinn RJ (July 1998). "Eudistomin V, a new beta-carboline from the Australian ascidian Pseudodistoma aureum". Journal of Natural Products. 61 (7): 959–960. doi:10.1021/np9800452. PMID9677285.
Becher PG, Beuchat J, Gademann K, Jüttner F (December 2005). "Nostocarboline: isolation and synthesis of a new cholinesterase inhibitor from Nostoc 78-12A". Journal of Natural Products. 68 (12): 1793–1795. doi:10.1021/np050312l. PMID16378379.
Herraiz T, González D, Ancín-Azpilicueta C, Arán VJ, Guillén H (March 2010). "beta-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO)". Food and Chemical Toxicology. 48 (3): 839–845. doi:10.1016/j.fct.2009.12.019. hdl:10261/77694. PMID20036304.
Glennon RA, Dukat M, Grella B, Hong S, Costantino L, Teitler M, et al. (August 2000). "Binding of beta-carbolines and related agents at serotonin (5-HT(2) and 5-HT(1A)), dopamine (D(2)) and benzodiazepine receptors". Drug and Alcohol Dependence. 60 (2): 121–132. doi:10.1016/s0376-8716(99)00148-9. PMID10940539.
Fortunato JJ, Réus GZ, Kirsch TR, Stringari RB, Fries GR, Kapczinski F, et al. (October 2010). "Chronic administration of harmine elicits antidepressant-like effects and increases BDNF levels in rat hippocampus". Journal of Neural Transmission. 117 (10): 1131–1137. doi:10.1007/s00702-010-0451-2. PMID20686906. S2CID21595062.
López-Muñoz F, Alamo C (2009-05-01). "Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today". Current Pharmaceutical Design. 15 (14): 1563–1586. doi:10.2174/138161209788168001. PMID19442174.
Wernicke C, Hellmann J, Zieba B, Kuter K, Ossowska K, Frenzel M, et al. (January 2010). "9-Methyl-beta-carboline has restorative effects in an animal model of Parkinson's disease". Pharmacological Reports. 62 (1): 35–53. doi:10.1016/s1734-1140(10)70241-3. PMID20360614. S2CID16729205.
Hamann J, Wernicke C, Lehmann J, Reichmann H, Rommelspacher H, Gille G (March 2008). "9-Methyl-beta-carboline up-regulates the appearance of differentiated dopaminergic neurones in primary mesencephalic culture". Neurochemistry International. 52 (4–5): 688–700. doi:10.1016/j.neuint.2007.08.018. PMID17913302. S2CID24226033.
Polanski W, Reichmann H, Gille G (June 2011). "Stimulation, protection and regeneration of dopaminergic neurons by 9-methyl-β-carboline: a new anti-Parkinson drug?". Expert Review of Neurotherapeutics. 11 (6): 845–860. doi:10.1586/ern.11.1. PMID21651332. S2CID24899640.
Foley P (2003). "Beans, roots and leaves: a brief history of the pharmacological therapy of parkinsonism". Wurzburger Medizinhistorische Mitteilungen. 22: 215–234. PMID15641199.
Schwarz MJ, Houghton PJ, Rose S, Jenner P, Lees AD (June 2003). "Activities of extract and constituents of Banisteriopsis caapi relevant to parkinsonism". Pharmacology, Biochemistry, and Behavior. 75 (3): 627–633. doi:10.1016/s0091-3057(03)00129-1. PMID12895680. S2CID28243440.
Brierley DI, Davidson C (January 2013). "Harmine augments electrically evoked dopamine efflux in the nucleus accumbens shell". Journal of Psychopharmacology. 27 (1): 98–108. doi:10.1177/0269881112463125. PMID23076833. S2CID40115950.
Hemmateenejad B, Abbaspour A, Maghami H, Miri R, Panjehshahin MR (August 2006). "Partial least squares-based multivariate spectral calibration method for simultaneous determination of beta-carboline derivatives in Peganum harmala seed extracts". Analytica Chimica Acta. 575 (2): 290–299. Bibcode:2006AcAC..575..290H. doi:10.1016/j.aca.2006.05.093. PMID17723604.
Herraiz T, González D, Ancín-Azpilicueta C, Arán VJ, Guillén H (March 2010). "beta-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO)". Food and Chemical Toxicology. 48 (3): 839–845. doi:10.1016/j.fct.2009.12.019. hdl:10261/77694. PMID20036304.
Badre A, Boulanger A, Abou-Mansour E, Banaigs B, Combaut G, Francisco C (April 1994). "Eudistomin U and isoeudistomin U, new alkaloids from the Caribbean ascidian Lissoclinum fragile". Journal of Natural Products. 57 (4): 528–533. doi:10.1021/np50106a016. PMID8021654.
Davis RA, Carroll AR, Quinn RJ (July 1998). "Eudistomin V, a new beta-carboline from the Australian ascidian Pseudodistoma aureum". Journal of Natural Products. 61 (7): 959–960. doi:10.1021/np9800452. PMID9677285.
Becher PG, Beuchat J, Gademann K, Jüttner F (December 2005). "Nostocarboline: isolation and synthesis of a new cholinesterase inhibitor from Nostoc 78-12A". Journal of Natural Products. 68 (12): 1793–1795. doi:10.1021/np050312l. PMID16378379.
Wernicke C, Hellmann J, Zieba B, Kuter K, Ossowska K, Frenzel M, et al. (January 2010). "9-Methyl-beta-carboline has restorative effects in an animal model of Parkinson's disease". Pharmacological Reports. 62 (1): 35–53. doi:10.1016/s1734-1140(10)70241-3. PMID20360614. S2CID16729205.
Hamann J, Wernicke C, Lehmann J, Reichmann H, Rommelspacher H, Gille G (March 2008). "9-Methyl-beta-carboline up-regulates the appearance of differentiated dopaminergic neurones in primary mesencephalic culture". Neurochemistry International. 52 (4–5): 688–700. doi:10.1016/j.neuint.2007.08.018. PMID17913302. S2CID24226033.
Polanski W, Reichmann H, Gille G (June 2011). "Stimulation, protection and regeneration of dopaminergic neurons by 9-methyl-β-carboline: a new anti-Parkinson drug?". Expert Review of Neurotherapeutics. 11 (6): 845–860. doi:10.1586/ern.11.1. PMID21651332. S2CID24899640.
Schwarz MJ, Houghton PJ, Rose S, Jenner P, Lees AD (June 2003). "Activities of extract and constituents of Banisteriopsis caapi relevant to parkinsonism". Pharmacology, Biochemistry, and Behavior. 75 (3): 627–633. doi:10.1016/s0091-3057(03)00129-1. PMID12895680. S2CID28243440.
Brierley DI, Davidson C (January 2013). "Harmine augments electrically evoked dopamine efflux in the nucleus accumbens shell". Journal of Psychopharmacology. 27 (1): 98–108. doi:10.1177/0269881112463125. PMID23076833. S2CID40115950.
Du W, Aloyo VJ, Harvey JA (October 1997). "Harmaline competitively inhibits [3H]MK-801 binding to the NMDA receptor in rabbit brain". Brain Research. 770 (1–2): 26–29. doi:10.1016/s0006-8993(97)00606-9. PMID9372198. S2CID10309111.